Clinical and immunological relationships in patients with early schizophrenia

Serazetdinova V.S.; Petrova N.N.; Dorofeykov V.V.; Mayorova M.A.

doi:https://doi.org/10.17116/jnevro202512502135

Serazetdinova V.S.

N.P. Bechtereva Institute of the Human Brain

ORCID: 0000-0002-3404-0786

Petrova N.N.

Saint-Petersburg State University

ORCID: 0000-0003-4096-6208

Dorofeykov V.V.

Lesgaft National State University of Physical Culture, Sports and Health

ORCID: 0000-0002-7272-1654

Mayorova M.A.

Psycho-Neurological Dispensary No. 1

ORCID: 0000-0002-4932-4749

Clinical and immunological relationships in patients with early schizophrenia

Authors:

Serazetdinova V.S., Petrova N.N., Dorofeykov V.V., Mayorova M.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(2): 35‑42

DOI: 10.17116/jnevro202512502135

Read: 1031 times

Contact the author

Table of contents

To cite this article:

Serazetdinova VS, Petrova NN, Dorofeykov VV, Mayorova MA. Clinical and immunological relationships in patients with early schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(2):35‑42. (In Russ.)
https://doi.org/10.17116/jnevro202512502135

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

OBJECTIVE

To study clinical and immunological relationships in patients with early schizophrenia during remission.

MATERIAL AND METHODS

Forty-eight patients (53% females and 47% males) were examined at the initial stage of schizophrenia during remission (age 28.3±5.8 years). The duration of the disease was 2.7±1.3 years. The control group consisted of healthy males and females aged 18 to 30 years. The study used clinical-psychopathological and laboratory methods, as well as scale assessment.

RESULTS

In patients with early schizophrenia in remission, in 70% of cases, there was an increase in blood levels of cytokines IL-6, IL-9, IL-10, IL-13, IL-22, TNF-α, CCL20/MIP3α (p<0.001) compared to the control group. Levels of IL-4 (r=0.45; p=0.023) and IL-9 (r=0.48; p=0.014) correlated with disease duration. The PANSS composite index correlated with IL-6 levels (r=0.46; p=0.022). Levels of several pro-inflammatory blood cytokines were significantly higher in patients treated with first-generation antipsychotics compared with patients treated with second-generation antipsychotics (p<0.001).

CONCLUSION

Changes in the concentrations of pro-inflammatory and anti-inflammatory interleukins, which are involved in the development of a nonspecific immune response as part of the systemic inflammatory response in patients with early schizophrenia during remission, have been demonstrated. The results suggest that in patients with the first episode of schizophrenia, the activation of immune inflammation plays a significant role in the development of the disease. Over time, such activation may stabilize and is associated with a greater severity of psychopathological symptoms.

Keywords:

schizophrenia

early stage

first psychotic episode

remission

antipsychotic therapy

cytokines

Authors:

Serazetdinova V.S.

N.P. Bechtereva Institute of the Human Brain

ORCID: 0000-0002-3404-0786

Petrova N.N.

Saint-Petersburg State University

ORCID: 0000-0003-4096-6208

Dorofeykov V.V.

Lesgaft National State University of Physical Culture, Sports and Health

ORCID: 0000-0002-7272-1654

Mayorova M.A.

Psycho-Neurological Dispensary No. 1

ORCID: 0000-0002-4932-4749

Received:

17.07.2024

Accepted:

14.11.2024

Close metadata

References:

LaLLy J, Ajnakina O, Stubbs B, et al. Remission and recovery from first episode psychosis in adults: systematic review and meta-anaLysis of Long-term outcome studies. British Journal of Psychiatry. 2017;211(06):350-358. https://doi.org/10.1192/bjp.bp.117.201475
Cullen AE, Holmes S, Pollak TA, et al. Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis. Biol Psychiatry. 2019;85(1):35-48. https://doi.org/10.1016/j.biopsych.2018.06.016
Dahan S, Bragazzi NL, Yogev A, et al. The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia. Psychiatry Res. 2018;268:467-472. https://doi.org/10.1016/j.psychres.2018.07.041
Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801-808. https://doi.org/10.1016/j.biopsych.2007.09.024
Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663-671. https://doi.org/10.1016/j.biopsych.2011.04.013
Kunz M, Ceres Ãr KM, Goi PD, et al. Serum levels of IL-6, IL-10 and TNF-± in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr. 2011;33:268-274. https://doi.org/10.1590/S1516-44462011000300010
Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696. https://doi.org/10.1038/mp.2016.3
Mondelli V, Cattaneo A, Belvederi Murri M, et al. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry. 2011;72:1677-1684. https://doi.org/10.4088/JCP.10m06745
Cannon TD, Chung Y, He G, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015;77:147-157. https://doi.org/10.1016/j.biopsych.2014.05.023
Lesh TA, Careaga M, Rose DR, et al. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation. 2018;15:165. https://doi.org/10.1186/s12974-018-1197-2
Halstead S, Siskind D, Amft M, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260-271. https://doi.org/10.1016/S2215-0366(23)00025-1
Frydecka D, Krzystek-Korpacka M, Lubeiro A, et al. Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study. Brain Behav Immun. 2018;71:28-36. https://doi.org/10.1016/j.bbi.2018.05.002
Wei L, Du Y, Wu W, et al. Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients. J Affect Disord. 2018;226:307-312. https://doi.org/10.1016/j.jad.2017.10.002
Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord. 2015;182:106-114. https://doi.org/10.1016/j.jad.2015.04.044
Zhu F, Zhang L, Liu F, et al. Altered serum tumor necrosis factor and interleukin-1ß in first-episode drug-naive and chronic schizophrenia. Front Neurosci. 2018;11;12:296. https://doi.org/10.3389/fnins.2018.00296
Klyushnik TP, Smulevich AB, Zozulya SA, Voronova EI. Neurobiology of schizophrenia and clinical and psychopathologic correlates (to the construction of clinical and biological model). Psychiatry. 2021;19(1):6-15. (In Russ.). https://doi.org/10.30629/2618-6667-2021-19-1-6-15
Mosolov SN, Potapov AV, Shafarenko AA, et al. Validation of standardized clinical and functional criteria for remission in schizophrenia. Modern therapy of psychiatric disorders. Modern therapy of psychiatric disorders. 2011;21(3):36-42. (In Russ.).
Thibaut F. Neuroinflammation: new vistas for neuropsychiatric research. Dialogues Clin Neurosci. 2017;19(1):3-4. https://doi.org/10.31887/DCNS.2017.19.1/fthibaut
Simbirtsev AS, Totolyan A.A. Cytokines in laboratory diagnostics. Infectious diseases: news, opinions, training. 2015;2(11):82-98. (In Russ.).
Totolyan AA. Modern approaches to diagnostics of immunopathologic states. Medical Immunology. 1999;1(1-2):75-108. (In Russ.).
Арсентьева Н.А., Любимова Н.Е., Бацунов О.К. и др. Цитокины в плазме крови больных covid-19 в острой фазе заболевания и фазе полного выздоровления. Медицинская иммунология. 2021;23(2):311-326.
Arsentieva NA, Lyubimova NE, Batsunov OK, et al. Cytokines in the plasma of covid-19 patients in the acute phase of the disease and the phase of complete recovery. Medical Immunology. 2021;23(2):311-326. (In Russ.). https://doi.org/10.15789/1563-0625-PCI-2312
Swerdlow NR, van Bergeijk DP, Bergsma F, Weber E, Talledo J. The effects of memantine on prepulse inhibition. Neuropsychopharmacology. 2009;34(7):1854-1864. https://doi.org/10.1038/npp.2009.7
Miüller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl. 2007;72:269-280. https://doi.org/10.1007/978-3-211-73574-9_33
Winter C, Djodari-Irani A, Sohr R, et al. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol. 2009;12(4):513-524. https://doi.org/10.1017/S1461145708009206
Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006;32(2):200-202. https://doi.org/10.1093/schbul/sbj052
Klyushnik TP, Zozulya SA, Androsova LV, et al. Laboratornaya diagnostika v monitoringe patsientov s endogennymi psikhozami («Neiro-immuno-test»): Meditsinskaya tekhnologiya. 2-e izd., ispr. i dop. M.: OOO «Izdatel’stvo «Meditsinskoe informatsionnoe agentstvo». 2016. (In Russ.).
Barron H, Hafizi S, Andreazza AC, Mizrahi R. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci. 2017;18(3):651. https://doi.org/10.3390/ijms18030651
Klyushnik TP, Zozulya SA, Oleichik IV. Biologicheskie marker shizofrenii: poisk i klinicheskoe primenenie. Novosibirsk: Izd-vo IEOPP SO RAN. 2017. (In Russ.).
Zozulya SA, Oleichik IV, Androsova LV, et al. Monitoring techeniya endogennykh psikhozov po immunologicheskim pokazatelyam. Psikhicheskoe zdorov’e. 2017;1:11-18. (In Russ.). https://psychiatr.ru/news/625
Hanson DR, Gottesman II. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet. 2005;6:7. https://doi.org/10.1186/1471-2350-6-7
Müller N, Riedel M, Ackenheil M, Schwarz MJ. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry. 2000;1(4):173-179. https://doi.org/10.3109/15622970009150588
Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun. 2006;20(6):532-545. https://doi.org/10.1016/j.bbi.2006.02.002
Vetlugina TP, Nikitina VB, Lobacheva OA, et al. Immunological criteria of prediction of course and therapy of mental disorders. Sibirskii Vestnik Psikhiatrii i Narkologii. 2016;2(91):10-14. (In Russ.). https://elibrary.ru/item.asp?id=26110144
Zhang XY, Zhou DF, Qi LY, et al. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology. 2009;204(1):177-184. https://doi.org/10.1007/s00213-008-1447-6
Kato T, Monji A, Hashioka S, Kanba S. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res. 2007;92(1-3):108-115. https://doi.org/10.1016/j.schres.2007.01.019
Malashenkova IK, Krynskiy SA, Ogurtsov DP, et al. A role of the immune system in the pathogenesis of schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12):72-80. (In Russ.). https://doi.org/10.17116/jnevro201811812172